Skip to content
PICO Portalanswers from OpenAlex

Risk of ophthalmic adverse events in patients treated with immune checkpoint inhibitor regimens: A systematic review and meta-analysis

PaperCitations, authors & open-access status

Risk of ophthalmic adverse events in patients treated with immune checkpoint inhibitor regimens: A systematic review and meta-analysis is a paper indexed in PICO Portal from OpenAlex.

How many citations does Risk of ophthalmic adverse events in patients treated with immune checkpoint inhibitor regimens: A systematic review and meta-analysis have?

PICO Portalcitation count

Risk of ophthalmic adverse events in patients treated with immune checkpoint inhibitor regimens: A systematic review and meta-analysis has 0 citations in the OpenAlex counts PICO Portal stores.

When was Risk of ophthalmic adverse events in patients treated with immune checkpoint inhibitor regimens: A systematic review and meta-analysis published?

PICO Portalyear

Risk of ophthalmic adverse events in patients treated with immune checkpoint inhibitor regimens: A systematic review and meta-analysis has 2019 year in the PICO Portal index.

What is the open-access status of Risk of ophthalmic adverse events in patients treated with immune checkpoint inhibitor regimens: A systematic review and meta-analysis?

PICO Portaloa status

Risk of ophthalmic adverse events in patients treated with immune checkpoint inhibitor regimens: A systematic review and meta-analysis has green oa status in the PICO Portal index.

What is the DOI of Risk of ophthalmic adverse events in patients treated with immune checkpoint inhibitor regimens: A systematic review and meta-analysis?

PICO Portaldoi

The DOI for Risk of ophthalmic adverse events in patients treated with immune checkpoint inhibitor regimens: A systematic review and meta-analysis is on the source record.

What is the OpenAlex record for Risk of ophthalmic adverse events in patients treated with immune checkpoint inhibitor regimens: A systematic review and meta-analysis?

PICO Portalopenalex

The OpenAlex for Risk of ophthalmic adverse events in patients treated with immune checkpoint inhibitor regimens: A systematic review and meta-analysis is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial